Best Practices

How Pharmaceutical Companies Can Protect Valuable IP

Intellectual property (IP) is the lifeblood of pharmaceutical companies. An analysis of the top 10 drug firms indicates that average R&D spend is over 20% of revenue and intangible assets.

Download the Datasheet

Select language to download

Instant Free Access

First name*

Last name*

Business e-mail*

Country/Region

I agree to the processing of my personal data by Vectra AI, Inc., and to Vectra’s Terms of Use and Vectra’s Privacy Policy. I understand I may unsubscribe from Vectra communications at any time.*

Thank you for downloading!

Please access your free offer below.

Download your asset

Oops! Something went wrong while submitting the form.